Syringes and Needles - Medical Devices Pipeline Assessment, 2019

Syringes and Needles are medical instruments used to inject a drug or extract body fluids. GlobalData's Medical Devices sector report, “Syringes and Needles - Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Syringes and Needles pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Syringes and Needles Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Syringes and Needles under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Syringes and Needles pipeline products.

Review of Recent Developments in the segment / industry

The Syringes and Needles Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Syringes and Needles under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023
  • 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
  • 56,000+ medical equipment company profiles
  • 4,300+ company profiles of medical equipment manufacturers in China and India
  • 2,000+ company profiles of medical equipment manufacturers in Japan
  • 825+ companies’ revenue splits and market shares
  • 1,900+ quarterly and annual medical equipment company financials
  • 940+ medical equipment company SWOTs
  • 21,500+ pipeline product profiles
  • 34,500+ marketed product profiles
  • 36,000+ clinical trials
  • 36,500+ trial investigators
  • 5,400+ reports on companies with products in development
  • 33,000+ deals in the medical equipment industry
  • 1,300+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Syringes and Needles under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Syringes and Needles and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Syringes and Needles under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Aquabiliti

ARTE CORPORATION

Baxter International Inc

Becton Dickinson and Co

Cincinnati Children's Hospital Medical Center

Cook Regentec LLC

Daxor Corp

Galderma SA

Globe Medical Tech ...

Aquabiliti

ARTE CORPORATION

Baxter International Inc

Becton Dickinson and Co

Cincinnati Children's Hospital Medical Center

Cook Regentec LLC

Daxor Corp

Galderma SA

Globe Medical Tech Inc (Inactive)

Injeq Oy

iScience Interventional Inc

Johns Hopkins University

Medigard Ltd

MonuMedical LLC

Neuroelectrics

NuvOx Pharma LLC

Olberon Medical Innovation SAS

Protectus Medical Devices, Inc.

Resultados y Calidad del Sistema Sanitario Publico de Andalucia

Rutgers The State University of New Jersey

Silmag SA

Syrindicare, Inc

Telezon Ltd

Unilife Corporation

University of California Berkeley

University of California Irvine

University of Louisville

University of Massachusetts Amherst

University of South Florida

Virginia Commonwealth University

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Syringes and Needles ...

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Syringes and Needles Overview 8

3 Products under Development 9

3.1 Syringes and Needles - Pipeline Products by Stage of Development 9

3.2 Syringes and Needles - Pipeline Products by Segment 10

3.3 Syringes and Needles - Pipeline Products by Territory 11

3.4 Syringes and Needles - Pipeline Products by Regulatory Path 12

3.5 Syringes and Needles - Pipeline Products by Estimated Approval Date 13

4 Syringes and Needles - Pipeline Products under Development by Companies 14

4.1 Syringes and Needles Companies - Pipeline Products by Stage of Development 14

4.2 Syringes and Needles - Pipeline Products by Stage of Development 16

5 Syringes and Needles Companies and Product Overview 18

5.1 Aquabiliti Company Overview 18

5.1.1 Aquabiliti Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 ARTE CORPORATION Company Overview 20

5.2.1 ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Baxter International Inc Company Overview 21

5.3.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Becton Dickinson and Co Company Overview 22

5.4.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Cincinnati Children's Hospital Medical Center Company Overview 25

5.5.1 Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Cook Regentec LLC Company Overview 26

5.6.1 Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Daxor Corp Company Overview 27

5.7.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Galderma SA Company Overview 28

5.8.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Globe Medical Tech Inc (Inactive) Company Overview 29

5.9.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Injeq Oy Company Overview 32

5.10.1 Injeq Oy Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 iScience Interventional Inc Company Overview 33

5.11.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Johns Hopkins University Company Overview 34

5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Medigard Ltd Company Overview 35

5.13.1 Medigard Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

5.14 MonuMedical LLC Company Overview 38

5.14.1 MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Neuroelectrics Company Overview 39

5.15.1 Neuroelectrics Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 NuvOx Pharma LLC Company Overview 40

5.16.1 NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 Olberon Medical Innovation SAS Company Overview 41

5.17.1 Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 Protectus Medical Devices, Inc. Company Overview 42

5.18.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 43

5.19.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 Rutgers The State University of New Jersey Company Overview 44

5.20.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 Silmag SA Company Overview 45

5.21.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 Syrindicare, Inc Company Overview 46

5.22.1 Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Telezon Ltd Company Overview 47

5.23.1 Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 Unilife Corporation Company Overview 49

5.24.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 49

5.25 University of California Berkeley Company Overview 54

5.25.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 54

5.26 University of California Irvine Company Overview 55

5.26.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 55

5.27 University of Louisville Company Overview 56

5.27.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 University of Massachusetts Amherst Company Overview 57

5.28.1 University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 University of South Florida Company Overview 58

5.29.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 58

5.30 Virginia Commonwealth University Company Overview 59

5.30.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 59

6 Syringes and Needles- Recent Developments 60

6.1 Jul 13, 2018: Vitrolife: Interim report January – June 2018 60

6.2 Jul 12, 2018: Personnel Changes in Supervisory and Management Board of Aesculap 60

6.3 Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 60

6.4 Jul 08, 2018: Vetter Strikes out on New Pathways to Further Develop the Injection Process 61

6.5 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes 62

6.6 Jun 27, 2018: Finnish Lojer to acquire the Nordics’ largest supplier of acupuncture needles 63

6.7 Jun 26, 2018: InfuSystem Holdings Selected as an Official Distributor of CADD Infusion Therapy Products by Smiths Medical 63

6.8 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 64

6.9 Jun 21, 2018: Clinical Innovations to Host Forum, Demonstrate Products at Association of Women’s Health, Obstetric and Neonatal Nurses Convention 64

6.10 Jun 21, 2018: West Pharmaceutical Services names Bernard Birkett As Chief Financial Officer 65

6.11 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia 65

6.12 Jun 12, 2018: Daxor Names Kathryn A. Kornafel As Vice President Of Marketing And Commercial Development 67

6.13 Jun 08, 2018: B. Braun to Showcase Its Commitment to Reducing Healthcare-Associated Infections with Products and Education at APIC 2018 68

6.14 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 69

6.15 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 69

6.16 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 70

6.17 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 70

6.18 May 18, 2018: West Introduces New Analytical Services Capabilities 73

6.19 May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection 73

6.20 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4% 73

6.21 May 14, 2018: Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection 74

6.22 May 11, 2018: Terumo Appoints its U.S. based Subsidiary's Associate as the Fifth Terumo Fellow 74

6.23 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 75

6.24 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 75

6.25 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018 77

6.26 Apr 30, 2018: Analytica: Appendix 4C – Quarterly Cash Flow Report 79

6.27 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles 80

6.28 Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results 80

6.29 Apr 26, 2018: West Announces First-Quarter 2018 Results 81

6.30 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 83

6.31 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 84

6.32 Apr 25, 2018: KARL STORZ OR1 Operating Rooms – Now Assisting the Surgical Team at Spital Thun, Switzerland 85

6.33 Apr 24, 2018: Vitrolife: Interim Report January – March 2018: High Profitability and Time-lapse Growth 86

6.34 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 86

6.35 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 86

6.36 Apr 17, 2018: SCHOTT Introduces syriQ BioPure for Sensitive Drugs 87

6.37 Apr 17, 2018: Guangzhou Improve Medical, a leading global IVD company, receives FDA registration renewal 88

6.38 Apr 13, 2018: Medisystems Announces US Release of MasterGuard Plus 89

6.39 Apr 12, 2018: Gerresheimer raises earnings per share in first quarter due to US tax reform 89

6.40 Apr 09, 2018: RMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.'s Patent, Nullifying Infringement Claim 90

6.41 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 91

6.42 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017 91

6.43 Mar 29, 2018: Albert David Announces Personnel Changes 92

6.44 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 92

6.45 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement 95

6.46 Mar 19, 2018: Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations 95

7 Appendix 96

7.1 Methodology 96

7.2 About GlobalData 99

7.3 Contact Us 99

7.4 Disclaimer 99

List of Tables

Table 1: Syringes and Needles - Pipeline Products by Stage of Development 9

Table 2: Syringes and Needles - Pipeline Products by Segment 10

Table 3: Syringes ...

Table 1: Syringes and Needles - Pipeline Products by Stage of Development 9

Table 2: Syringes and Needles - Pipeline Products by Segment 10

Table 3: Syringes and Needles - Pipeline Products by Territory 11

Table 4: Syringes and Needles - Pipeline Products by Regulatory Path 12

Table 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 13

Table 6: Syringes and Needles Companies - Pipeline Products by Stage of Development 14

Table 7: Syringes and Needles - Pipeline Products by Stage of Development 16

Table 8: Aquabiliti Pipeline Products & Ongoing Clinical Trials Overview 18

Table 13: ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 20

Table 16: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 19: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 22

Table 28: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 25

Table 31: Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Table 34: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 28

Table 40: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

Table 47: Injeq Oy Pipeline Products & Ongoing Clinical Trials Overview 32

Table 50: iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 53: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 34

Table 56: Medigard Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

Table 63: MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Table 66: Neuroelectrics Pipeline Products & Ongoing Clinical Trials Overview 39

Table 69: NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Table 72: Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 41

Table 75: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 78: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 43

Table 81: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 44

Table 84: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 45

Table 87: Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 90: Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Table 95: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 49

Table 110: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 54

Table 113: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 55

Table 116: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 56

Table 119: University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 57

Table 122: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 58

Table 125: Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 59

Table 128: Glossary 98

List of Figures

Figure 1: Syringes and Needles - Pipeline Products by Stage of Development 9

Figure 2: Syringes and Needles - Pipeline Products by Segment 10

Figure 3: Syringes ...

Figure 1: Syringes and Needles - Pipeline Products by Stage of Development 9

Figure 2: Syringes and Needles - Pipeline Products by Segment 10

Figure 3: Syringes and Needles - Pipeline Products by Territory 11

Figure 4: Syringes and Needles - Pipeline Products by Regulatory Path 12

Figure 5: Syringes and Needles - Pipeline Products by Estimated Approval Date 13

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports